38 results on '"Vogelmeier, C.F."'
Search Results
2. Dupilumab Does Not Impact Blood Eosinophil Levels in Patients With Moderate-to-Severe COPD and Type 2 Inflammation: From the Phase 3 Boreas Trial
3. Dupilumab Improves Pre-bronchodilator Lung Function Measures in Patients With Chronic Obstructive Pulmonary Disease (COPD) With Type 2 Inflammation: Data From the Phase 3 Boreas Trial
4. Dupilumab Increases the Proportion of Patients With Fractional Exhaled Nitric Oxide Levels <20 ppb Over Time in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease and Type 2 Inflammation: From Phase 3 Boreas
5. Dupilumab Improves Post-bronchodilator Lung Function in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Type 2 Inflammation: Data From the Phase 3 Boreas Trial
6. In the Phase 3 Boreas Trial, Baseline Blood Eosinophils and Baseline Fractional Exhaled Nitric Oxide Levels Predict the Response to Dupilumab in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
7. Efficacy and Safety of Dupilumab in Patients With Moderate-to-Severe COPD and Type 2 Inflammation: Phase 3 NOTUS Trial
8. In The Phase 3 Boreas Trial, Dupilumab Reduced FeNO Levels Over Time in Patients With Moderate-to-Severe COPD With Type 2 Inflammation
9. Impaired Left Ventricular Filling and All-cause Mortality in COPD
10. Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD: Results from the COSYCONET cohort
11. RWD25 Healthcare Resource Utilization and Costs in Patients Experiencing Severe Cardiac Events Following a COPD Exacerbation: Results from EXACOS-CV Studies in Spain, Germany, the Netherlands and Canada
12. Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With COPD
13. Impact of the ERS/ATS 2021 Guidelines for Lung Function Interpretation
14. Herz-Lungen-Interaktion bei COPD: Pneumo meets Kardio
15. Alpha1-antitrypsin deficiency in Greece: Focus on rare variants
16. Α1-ANTITRYPSIN DEFICIENCY IN GREEKS: FOCUS ON RARE VARIANTS
17. Comparative Efficacy of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Versus Other Triple Therapies for the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review and Network Meta-Analysis
18. mHealth Telemonitoring of Long COVID-19: A Mixed Methods Study on Challenges, Technology Acceptance and Perceived Added value
19. Network Meta-Analysis of the Efficacy of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Versus Other Triple Therapies for the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Comparison of Annual Moderate and Severe Exacerbations
20. Associations of oxygenated hemoglobin with disease burden and prognosis in stable COPD: Results from COSYCONET
21. Relation entre le test d’évaluation de la BPCO et le questionnaire respiratoire de St George chez les patients atteints de BPCO : une analyse post-hoc des essais IMPACT, FULFIL et EMAX
22. Die chronisch-obstruktive Lungenerkrankung (COPD): Aktuelle Konzepte und neue Therapieoptionen
23. Herz und Lunge: Leitsymptom Dyspnoe
24. Improving lung health in low-income and middle-income countries: from challenges to solutions
25. PRS10 Economic Evaluation of Umeclidinium/Vilanterol Versus Umeclidinium or Salmeterol in a UK COPD Population at Low Risk of Exacerbations Using the GALAXY Model
26. Validation of the Chronic Airways Assessment Test in the NOVELTY Study
27. Sensitivity of the Evaluating Respiratory Symptoms in Chronic Obstructive Pulmonary Disease (E-RS™:COPD) Diary Scores: A Rapid Systematic Literature Review
28. COPD Maintenance Medication Is Linked to Left Atrial Size: Results from the COSYCONET Cohort
29. Machine Learning Model for Asthma/COPD Differentiation Classification (ACDC) Outperforms Clinicians in a Retrospective Multiple-Rater Multiple-Case Review Study
30. Asthma/COPD Differentiation Classification (AC/DC): Machine Learning to Aid Physicians in Diagnosing Asthma, COPD and Asthma-COPD Overlap (ACO)
31. Estimation of Lung Hyperinflation via Conventional Spirometry: Results from COSYCONET
32. The Effect of Tiotropium/Olodaterol versus Salmeterol/Fluticasone on Left Ventricular Function and Lung Hyperinflation in Patients with COPD
33. Under Detection of Left Heart Failure in COPD: Results from the COSYCONET Cohort
34. The Effect of Tiotropium/Olodaterol versus Salmeterol/Fluticasone on Left Ventricular Function and Lung Hyperinflation in Patients with COPD
35. Zufallsbefunde in der Inneren Medizin
36. Exercise training leads to physiological left ventricular hypertrophy in COPD
37. Herz und Lunge
38. ABHÄNGIGKEIT NÄCHTLICHER BRONCHIALOBSTRUKTIONEN VON DER SCHLAFPOSITION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.